These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 19217025

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
    Chou YH, Halldin C, Farde L.
    Synapse; 2000 Nov; 38(2):138-43. PubMed ID: 11018787
    [Abstract] [Full Text] [Related]

  • 24. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
    de Paulis T.
    Curr Pharm Des; 2003 Nov; 9(8):673-96. PubMed ID: 12570798
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [Abstract] [Full Text] [Related]

  • 31. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N, Finnema SJ, Farde L, Gulyás B, Wikström HV, Halldin C, Innis RB.
    Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
    [Abstract] [Full Text] [Related]

  • 32. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
    Cervenka S, Varrone A, Fransén E, Halldin C, Farde L.
    Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
    [Abstract] [Full Text] [Related]

  • 33. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M.
    Synapse; 2004 Jun 01; 52(3):188-208. PubMed ID: 15065219
    [Abstract] [Full Text] [Related]

  • 34. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
    Olsson H, Halldin C, Farde L.
    Neuroimage; 2004 Jun 01; 22(2):794-803. PubMed ID: 15193608
    [Abstract] [Full Text] [Related]

  • 35. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H, van Balkom A, Lammertsma AA, van Berckel BN.
    Eur Neuropsychopharmacol; 2013 Nov 01; 23(11):1423-31. PubMed ID: 23876376
    [Abstract] [Full Text] [Related]

  • 36. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
    Olsson H, Halldin C, Swahn CG, Farde L.
    J Cereb Blood Flow Metab; 1999 Oct 01; 19(10):1164-73. PubMed ID: 10532641
    [Abstract] [Full Text] [Related]

  • 37. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.
    Laruelle M.
    J Cereb Blood Flow Metab; 2000 Mar 01; 20(3):423-51. PubMed ID: 10724107
    [Abstract] [Full Text] [Related]

  • 38. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A.
    Neuropsychopharmacology; 2008 Dec 01; 33(13):3111-25. PubMed ID: 18418366
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.